Common Contracts
2 similar Exclusive License Agreement contracts by Juno Therapeutics, Inc.
EX-10.7(A) 5 d772541dex107a.htm EXCLUSIVE LICENSE AGREEMENT, MEMORIAL SLOAN- KETTERING CANCER CENTER Execution Copy [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission....Exclusive License Agreement • May 5th, 2020 • New York
This Exclusive License Agreement (“Agreement”) is effective as of November 21, 2013 (“Effective Date”), and is by and between Memorial Sloan-Kettering Cancer Center (“MSKCC”), a New York corporation with principal offices at 1275 York Avenue, New York, NY 10065, and Juno Therapeutics, Inc., a Delaware corporation with principal offices at 8725 W. Higgins Road, Suite 290, Chicago, IL 60631 (“LICENSEE”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 17th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Exclusive License Agreement (“Agreement”) is effective as of November 21, 2013 (“Effective Date”), and is by and between Memorial Sloan-Kettering Cancer Center (“MSKCC”), a New York corporation with principal offices at 1275 York Avenue, New York, NY 10065, and Juno Therapeutics, Inc., a Delaware corporation with principal offices at 8725 W. Higgins Road, Suite 290, Chicago, IL 60631 (“LICENSEE”).
